|
|
|||||||||||||||
|
|
||||||||||||||||||
La Merie Business Intelligence Press Release - Lamerie.com |
|
12 FEB |
2008 Is A Decisive Year For The Validation Of The Asthma Target Interleukin-13 |
| Results of two major phase II studies in asthma expected during 2008 will be a GO/NO GO milestone for the field of interleukin-13 (IL-13) antagonists Barcelona, Spain | The Business Intelligence firm La Merie S.L. reported today that during the year 2008 results of major phase II studies in asthma w ... |
|
|||||||||||||||||||||
|
||
|
|
Sitemap|
Press Release Sitemap|
Latest Companies|
Buddies|
PR Guidelines|
Privacy Policy Terms of Use| Contact Us| Affiliate Program |
|